A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
Condition: Healthy Participants Interventions: Drug: Vepdegestrant; Drug: Carbamazepine Sponsors: Pfizer; Arvinas Estrogen Receptor, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.
Condition: Healthy Interventions: Drug: Sinsunatovir; Other: Bitrex Sponsor: Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults
Condition: Healthy Participants Interventions: Drug: PF-06954522; Drug: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
Condition: Healthy Participants Interventions: Drug: Vepdegestrant; Drug: Carbamazepine Sponsors: Pfizer; Arvinas Estrogen Receptor, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.
Condition: Healthy Interventions: Drug: Sinsunatovir; Other: Bitrex Sponsor: Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults
Condition: Healthy Participants Interventions: Drug: PF-06954522; Drug: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
Condition: Healthy Participants Interventions: Drug: Vepdegestrant; Drug: Carbamazepine Sponsors: Pfizer; Arvinas Estrogen Receptor, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
